These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15152472)

  • 1. [Prion protein structure and its relationships with pathogenesis].
    Muramoto T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):813-6. PubMed ID: 15152472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology and transgenetics of prion diseases.
    Prusiner SB
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFP-tagged PrP supports compromised prion replication in transgenic mice.
    Bian J; Nazor KE; Angers R; Jernigan M; Seward T; Centers A; Green M; Telling GC
    Biochem Biophys Res Commun; 2006 Feb; 340(3):894-900. PubMed ID: 16386707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into alternate aggregated prion protein forms.
    Polano M; Bek A; Benetti F; Lazzarino M; Legname G
    J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic mammalian prions.
    Legname G; Baskakov IV; Nguyen HO; Riesner D; Cohen FE; DeArmond SJ; Prusiner SB
    Science; 2004 Jul; 305(5684):673-6. PubMed ID: 15286374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-sheet constitution of prion proteins.
    Ji HF; Zhang HY
    Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
    Brown DR
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
    Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
    Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice.
    Barmada S; Piccardo P; Yamaguchi K; Ghetti B; Harris DA
    Neurobiol Dis; 2004 Aug; 16(3):527-37. PubMed ID: 15262264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.